| CTRI Number |
CTRI/2025/09/094706 [Registered on: 12/09/2025] Trial Registered Prospectively |
| Last Modified On: |
11/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Self Warming Blanket for Newborns] |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Helping Newborn Babies Stay Warm: A Study of a Novel Self Warming Blanket |
|
Scientific Title of Study
|
Efficacy of a Novel Self-Warming blanket for thermoregulation in Neonates - An Open labelled , parallel arm, Randomized Controlled Trial |
| Trial Acronym |
NeoSWaT |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DrPallavi Samariya |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences, Mangalagiri |
| Address |
Department of Pediatrics
All India Institute of Medical Sciences, Mangalagiri, Guntur- AP
Guntur ANDHRA PRADESH 522503 India |
| Phone |
8424064142 |
| Fax |
|
| Email |
pallavisamariya04@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DrPallavi Samariya |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences, Mangalagiri |
| Address |
Department of Pediatrics
All India Institute of Medical Sciences, Mangalagiri, Guntur- AP
ANDHRA PRADESH 522503 India |
| Phone |
8424064142 |
| Fax |
|
| Email |
pallavisamariya04@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Arun Babu T |
| Designation |
Professor and Head |
| Affiliation |
All India Institute of Medical Sciences, Mangalagiri |
| Address |
Department of Pediatrics
All India Institute of Medical Sciences, Mangalagiri, Guntur- AP
Guntur ANDHRA PRADESH 522503 India |
| Phone |
9944701700 |
| Fax |
|
| Email |
babuarun@yahoo.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences, Mangalagiri, Guntur, AP, India- 522503 |
|
|
Primary Sponsor
|
| Name |
Dr Pallavi Samariya |
| Address |
All India Institute of Medical Sciences, Mangalagiri, Guntur, Andhra Pradesh, India- 522503 |
| Type of Sponsor |
Other [Self funded] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pallavi Samariya |
All India Institute of Medical Sciences, Mangalagiri, Guntur, AP, India-522503 |
Room No-321,OPD Block,
Department of Pediatrics
Guntur ANDHRA PRADESH |
8424064142
pallavisamariya04@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC AIIMS Mangalagiri |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Stable newborn delivered between 30 and 40 weeks of gestation within first 28 days of life
|
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Conventional Blanket for Newborns |
Conventional Blanket for Newborns will be assigned for 8 hours to the selected participants based on randomisation to check for temerparature stability |
| Intervention |
Novel Self Warming Blanket |
Novel Self Warming Blanket will be assigned for 8 hours to the selected participants based on randomisation to check for temerparature stability |
|
|
Inclusion Criteria
|
| Age From |
0.00 Day(s) |
| Age To |
28.00 Day(s) |
| Gender |
Both |
| Details |
Stable newborn delivered between 30 and 40 weeks of gestation within first 28 days of life
|
|
| ExclusionCriteria |
| Details |
Newborns born before 30 weeks of gestation
Critically ill newborn requiring NICU admission
Newborn with major congenital malformations
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Proportion of newborns maintaining normal body temperature (36.5°C to 37.5°C) upon usage of novel self warming blanket vs conventional blanket |
Proportion of newborns maintaining normal body temperature (36.5°C to 37.5°C) during 8 hours of usage of novel self warming blanket vs conventional blanket |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| The trial also aims at evaluating any adverse events reported with usage of these blankets in newborn |
The newborns will be monitored for any side effects at baseline, as well continuous hourly monitoring will be done till 8 hours of usage of novel self warming blanket vs conventional blanket. |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
01/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="9" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Neonates satisfying the eligibility criteria will be enrolled in the study after obtaining written informed consent from the parents/legal guardian/caretaker Eligible newborns will then be randomized using a digitally generated sequence into two groups Group A will receive a Novel Self Warming Blanket and group B will receive the normal blanketThe procedure of randomization will be conducted by a person who has no role in the collection of data randomization analysis of data or allocation of the intervention A sequence with a random order will be derived using a software application. Randomization of the sequence will be further enhanced by generating tables of variable block sizes using computer software Concealment of the allocation of the intervention will be implemented by the usage of opaque chronologically numbered sealed envelopes each corresponding to the assigned sequence An open-label study design has been adopted due to the operational requirement for air activation of the heating element integrated within the self warming blanket A structured questionnaire will be used to gather demographic information and a comprehensive history regarding antenatal details maternal medication use etc will also be recorded Additionally a thorough physical examination will be conducted to assess for any systemic involvement. This Self-Warming blanket is specifically engineered to integrate two essential components a thermal blanket and a heating element The blanket is constructed from hypoallergenic fabric combined with hospital-grade polypropylene material and polyurethane foam, providing insulation to minimize heat loss in infants. While the insulating layer helps to slow down the loss of body heat, it alone is insufficient to maintain a thermoneutral temperature, as preterm infants lack the ability to generate adequate heat on their own To address this, the design includes a dedicated compartment for a heating element, which serves as a controlled and consistent external heat source This heating component is designed to maintain a stable thermoneutral temperature for up to 8 hours, ensuring the infant remains warm during critical periods such as transport or postnatal stabilizationThe heating element is strategically positioned on the back side of the blanket and is separated from the infant’s contact surface by four protective layers comprising fabric and foam. This multilayered barrier ensures that the heating element remains completely isolated thereby eliminating any risk of direct contact with the newborn The heating component utilizes ready-to-use air-activated heat packs which are widely employed globally for thermal insulation in cold environments These heat packs contain only non-toxic substances including iron salt water and insulating material such as vermiculite and activated carbon These materials are securely enclosed within multiple protective layers to prevent any leakage of the active ingredients Upon exposure to air, the iron within the mixture undergoes a controlled oxidation process converting to iron oxide (rust) which generates heat Owing to the gradual nature of this chemical reaction the heating pack is engineered to deliver warmth in a slow sustained manner maintaining a consistent temperature over an extended duration. Utilizing air activated heating technology, the Self Warming blanket becomes ready for use within 15 minutes of exposure to air and provides consistent warmth for up to 8 hoursAfter use, a heating element made with all non-toxic, eco-friendly ingredients can be safely disposed of with solid wasteThe product is tested within the laboratory for obtaining the temperature profile of the surface in contact with the babyThe temperature remains between 36.5 – 38.0 °C and slowly decreases over a period of time. There is no variation in Warm and Cold temperature while using the blanket
Following the initiation of the intervention, all newborns will be monitored continuously using a temperature probe with set limits with an alarm Assessment of the Prechtl score will also be done hourly over the next 8 hours to assess their condition After 8 hours of blanket usage, newborns will undergo a re-evaluation of the same parameters at 0 5 and 30-minute intervals This approach will facilitate a more detailed assessment of their temperature stability and ensure continuous and appropriate monitoring of their overall condition Any adverse effect noted during the usage of blanket will be documented |